Literature DB >> 2862915

Inhibition of energy-transducing reactions by 8-nitreno-ATP covalently bound to bovine heart submitochondrial particles: direct interaction between ATPase and redox enzymes.

M A Herweijer, J A Berden, A Kemp, E C Slater.   

Abstract

The photoaffinity label 8-azido-ATP has been used to study the effect of inhibition of ATP synthase on ATP-driven reverse electron transfer from succinate to NAD+ ('reversal'), succinate- and NADH-driven ATP synthesis and ATP-Pi exchange. In reversal, where ATPase functions as primary proton pump, inactivation by covalently bound nitreno-ATP results in an inhibition that is proportional to the inactivation of ATP hydrolysis, or, consequently, with the concentration of inactivated ATP synthases. Up to 60% inactivation of the reversal rate does not lead to a decrease in delta mu H+. Inhibition of ATP synthase as secondary proton pump results in case of NADH-driven ATP synthesis in a proportional inhibition, but with succinate as substrate ATP synthesis is less than proportionally inhibited, compared with inactivation of ATP hydrolysis. Inhibition of one of the primary pumps of NADH-driven ATP synthesis, the NADH:Q oxidoreductase, with rotenone also resulted in an inhibition of the rate of ATP synthesis proportional to that of the NADH oxidation. ATP-Pi exchange is much more affected than ATP hydrolysis by photoinactivation with 8-azido-ATP. Contrary to reversal and NADH-driven ATP synthesis the rate of ATP-Pi exchange does not depend linearly, but quadratically on the concentration of active ATP synthases. The observed proportional relationships between inhibition of the primary or secondary pump and the inhibition of the overall energy-transfer reactions do not support the existence of a pool intermediate in energy-transduction reactions. However, the results are consistent with a direct transfer of energy from redox enzymes to ATP synthase and vice versa.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2862915     DOI: 10.1016/0005-2728(85)90170-7

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  8 in total

1.  Exposure to the metabolic inhibitor sodium azide induces stress protein expression and thermotolerance in the nematode Caenorhabditis elegans.

Authors:  Michelle R Massie; Elizabeth M Lapoczka; Kristy D Boggs; Karen E Stine; Glenn E White
Journal:  Cell Stress Chaperones       Date:  2003       Impact factor: 3.667

Review 2.  Control of mitochondrial ATP synthesis in the heart.

Authors:  D A Harris; A M Das
Journal:  Biochem J       Date:  1991-12-15       Impact factor: 3.857

Review 3.  Role of energy in oxidative phosphorylation.

Authors:  A Matsuno-Yagi; Y Hatefi
Journal:  J Bioenerg Biomembr       Date:  1988-08       Impact factor: 2.945

4.  A high-throughput device for size based separation of C. elegans developmental stages.

Authors:  Xiaoni Ai; Weipeng Zhuo; Qionglin Liang; Patrick T McGrath; Hang Lu
Journal:  Lab Chip       Date:  2014-03-27       Impact factor: 6.799

5.  Nerve growth factor induces axonal filopodia through localized microdomains of phosphoinositide 3-kinase activity that drive the formation of cytoskeletal precursors to filopodia.

Authors:  Andrea Ketschek; Gianluca Gallo
Journal:  J Neurosci       Date:  2010-09-08       Impact factor: 6.167

6.  Alcohol disinhibition of behaviors in C. elegans.

Authors:  Stephen M Topper; Sara C Aguilar; Viktoria Y Topper; Erin Elbel; Jonathan T Pierce-Shimomura
Journal:  PLoS One       Date:  2014-03-28       Impact factor: 3.240

7.  ATP driven clathrin dependent entry of carbon nanospheres prefer cells with glucose receptors.

Authors:  Ruthrotha B Selvi; Snehajyoti Chatterjee; Dinesh Jagadeesan; Piyush Chaturbedy; Bangalore Srinivas Suma; Muthusamy Eswaramoorthy; Tapas K Kundu
Journal:  J Nanobiotechnology       Date:  2012-08-02       Impact factor: 10.435

8.  Regulation of extracellular matrix organization by BMP signaling in Caenorhabditis elegans.

Authors:  Robbie D Schultz; Emily E Bennett; E Ann Ellis; Tina L Gumienny
Journal:  PLoS One       Date:  2014-07-11       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.